Rationale Serious neurological concomitants of alcoholism include Wernicke's encephalopathy (WE), Korsakoff's syndrome (KS), and hepatic encephalopathy (HE). Objectives This study was conducted in animal models to determine neuroradiological signatures associated with liver damage caused by carbon tetrachloride (CCl 4 ), thiamine deficiency caused by pyrithiamine treatment, and nonspecific nutritional deficiency caused by food deprivation. Methods Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) were used to evaluate brains of wild-type Wistar rats at baseline and following treatment. Results Similar to observations in ethanol (EtOH) exposure models, thiamine deficiency caused enlargement of the lateral ventricles. Liver damage was not associated with effects on cerebrospinal fluid volumes, whereas food deprivation caused modest enlargement of the cisterns. In contrast to what has repeatedly been shown in EtOH exposure models, in which levels of choline-containing compounds (Cho) measured by MRS are elevated, Cho levels in treated animals in all three experiments (i.e., liver damage, thiamine deficiency, and food deprivation) were lower than those in baseline or controls. Conclusions These results add to the growing body of literature suggesting that MRS-detectable Cho is labile and can depend on a number of variables that are not often considered in human experiments. These results also suggest that reductions in Cho observed in humans with alcohol use disorder (AUD) may well be due to mild manifestations of concomitants of AUD such as liver damage or nutritional deficiencies and not necessarily to alcohol consumption per se.
Introduction
Chronic alcoholism is a complex disease associated with cognitive decline, brain structural degradation, and connectivity disruption (e.g., Camchong et al. 2013; Chanraud et al. 2013; Nixon et al. 2014; Oscar-Berman et al. 2014; Pfefferbaum and Sullivan 2005; Pitel et al. 2012) . Whether alcohol per se or the complications that arise with chronic alcohol use contributes to brain compromise remains controversial. Serious neurological concomitants of alcoholism include hepatic encephalopathy (HE), Wernicke's encephalopathy (WE), and Korsakoff's syndrome (KS) (Mann et al. 2003; Prasad et al. 2007) . HE is associated with confusion, altered levels of consciousness, or coma as a result of liver failure (Losowsky and Scott 1973; Vaquero et al. 2003) . WE is an acute, potentially reversible, neurological disorder resulting from thiamine (vitamin B 1 ) deficiency also characterized by acute mental confusion as well as ataxia and ophthalmoplegia. When WE is diagnosed, Electronic supplementary material The online version of this article (doi:10.1007/s00213-016-4313-y) contains supplementary material, which is available to authorized users. treatment with thiamine can result in rapid clinical improvement (Sechi and Serra 2007) . When left undiagnosed and untreated, WE patients can develop the severe, devastating neurologic disorder KS, characterized by memory loss, confabulation, and severe ataxia (Butters 1981; Harper et al. 1986) .
Questions persist regarding the relative contributions of mild, recurrent thiamine deficiency; liver damage; or other concomitants of alcoholism to the human brain. Animal models can be used to distinguish components of the processes associated with damage to the brain in response to alcohol exposure (Pfefferbaum et al. 2008; Zahr et al. 2010 Zahr et al. , 2014b Zahr et al. , 2013 Zahr et al. , 2009b Zahr et al. , 2015b . Our in vivo magnetic resonance imaging (MRI) studies of rats have consistently shown increases in cerebrospinal fluid (CSF) volumes following ethanol (EtOH) exposure. Chronic EtOH exposure via vapor inhalation with blood alcohol levels (BALs) up to 450 mg% resulted in modest (30 %) enlargement of the lateral ventricles (Pfefferbaum et al. 2008) . Intragastric (i.g.) EtOH for 4 days with BALs approaching 300 mg% was associated with reversible enlargements (upwards of 100 % increase) of the lateral ventricles (Zahr et al. 2010 (Zahr et al. , 2014b (Zahr et al. , 2013 . Repeated exposure to EtOH (5 cycles of 4 days of EtOH i.g. + 10 days of recovery) showed an increase of CSF volumes of the lateral ventricles and cisterns with each EtOH exposure, but recovery with each abstinence period.
Magnetic resonance spectroscopy (MRS) in the same models showed in the chronic study that N-acetylaspartate (NAA) levels were lower in the EtOH-exposed group relative to the control group but did not attain a statistical significance, while levels of choline-containing compounds (Cho) demonstrated a dose-response curve (i.e., increasing levels with higher/longer EtOH exposure) (Zahr et al. 2009b) . Changes in MRS metabolite levels were reversible following 1 week of recovery from 4 days of EtOH exposure (i.g.): levels of NAA decreased, while those of Cho increased (Zahr et al. 2010 (Zahr et al. , 2014b (Zahr et al. , 2013 . With repeated EtOH (i.g.) exposure, changes in metabolite levels did not accrue: levels of NAA decreased, while those of Cho increased with each EtOH exposure cycle but then recovered during each abstinence period (Zahr et al. 2015b ). Although these EtOH exposure studies were informative, they did not fully model the persistent ventricular enlargement seen in chronic alcoholism in humans (Pfefferbaum et al. 2012; Rosenbloom et al. 2010) nor the low levels of NAA (frontal regions: Bendszus et al. 2001; Durazzo et al. 2004 Durazzo et al. , 2010 Fein et al. 1994; Jagannathan et al. 1996; Parks et al. 2002; Schweinsburg et al. 2003; Seitz et al. 1999) and Cho (Bendszus et al. 2001; Durazzo et al. 2004 ; frontal regions: Ende et al. 2005; Fein et al. 1994; Parks et al. 2002; cerebellar regions: Seitz et al. 1999 ) observed in recently sober alcoholics relative to healthy controls.
Compared with controls, lower levels of both NAA and Cho are reported in MRS case studies of human WE (Mascalchi et al. 2002; Murata et al. 2001 ) and models of thiamine deficiency in rats treated with pyrithiamine hydrochloride (Lee et al. 2001 (Lee et al. , 1995 Pfefferbaum et al. 2007; Rose et al. 1993; Zahr et al. 2014a) . A reduction in Cho is also seen in patients with cirrhosis of the liver, along with a reduced signal from myo-inositol (mI) and an elevated signal from the combined resonance (Glx) of glutamate (Glu) and glutamine (Gln); typically, no effect of liver cirrhosis is observed on NAA levels (Cordoba et al. 2001; Geissler et al. 1997; Kreis et al. 1992; Laubenberger et al. 1997; Lee et al. 1999; Ross et al. 1994) . In animal models of liver disease, frequently reported MRS findings include reduced Cho, mI, and Glu, but elevated Gln (Bates et al. 1989; Chavarria et al. 2013; de Graaf et al. 1991; Peeling et al. 1993; Rackayova et al. 2015; Zwingmann et al. 2004) .
The current study included three experiments to evaluate the patterns of MRI and MRS changes in models of concomitants of alcoholism to compare the effects on the brain of EtOH exposure models. Acute hepatitis was induced using carbon tetrachloride (CCl4, Chavez-Pina et al. 2009 ). A food deprivation experiment was performed as a nonspecific nutritional deficiency and as a control for the EtOH (i.g.) exposure model (Majchrowicz 1975) , which has repeatedly resulted in a 20 % loss of body weight regardless of attempts to mitigate it (Zahr et al. 2009a (Zahr et al. , 2014b (Zahr et al. , 2013 ). An experiment combining thiamine deficiency and EtOH exposure was also conducted.
The key hypothesis to be tested was that concomitants of alcoholism such as liver damage and thiamine deficiency, unlike EtOH exposure, cause a decrease in Cho levels. It was further expected that a combination of thiamine deficiency and EtOH exposure would result in a net neutral effect on Cho levels (i.e., decrease in Cho due to thiamine deficiency would be canceled by the increase in Cho due to EtOH exposure).
Methods Animals
Wild-type Wistar rats from Charles River Laboratories, singly housed with free access to food and water and lights on for 12 h starting at 0600 hours were maintained in facilities fully accredited by the Association for the Assessment and 
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Liver damage model
This study group included 12 male rats weighing 311.6 ± 13.5 g at baseline (i.e., MR1). After acclimation to a new environment, including single housing, all animals (n = 12) underwent baseline scanning (MR1). Two days after scanning, six animals were given their first dose (2.5 ml/kg) of CCl 4 in olive oil (1:1) via intragastric oral gavage; a second dose (2.5 ml/kg) was administered on the following day. Control animals (n = 6) were given similar volumes of olive oil via intragastric oral gavage on each of the 2 days. Followup scans (MR2) were conducted the day after the second dose ( Fig. 1(a) ). Animals were euthanized the day following MR2.
Food deprivation model
After acclimation, all animals (n = 23), weighing an average of 329.1 ± 22.4 g, underwent baseline scanning (MR1). For this experiment, 12 animals were fasted for 12 h then fooddeprived (FD, i.e., given a limited number of food pellets) for a period of 4 days to 80 % of their baseline weight (i.e., 20 % weight loss as observed following i.g. EtOH exposure) and also deprived of water 12 h prior to the follow-up scan (MR2). Feces were removed from cages to avoid coprophagy, and body weights were taken daily. Control animals (n = 11) had ad libitum access to food and water during the course of the experiment. One control rat died immediately after MR2 of apparent anesthesia sensitivity. Immediately following MR2, FD animals were given ad libitum access to food and water, through a weeklong recovery period, after which all rats (n = 22) underwent a recovery scan (MR3, Fig. 1(b) ). One FD animal died immediately after the recovery scan. Of the food deprivation (FD) model, and c thiamine deficiency + ethanol (EtOH) model. Ctrl control, PE pyrithiamine-treated + EtOH, PS pyrithiaminetreated + saline, TE thiamine-treated + EtOH remaining 11 FD rats, six were exposed to another period of food restriction (4 days) before euthanasia, which was conducted 8 days following MR3. MRS data analysis included as many animals as possible (i.e., MRS1, n = 23; MRS2, n = 23; MRS3, n = 22); MRI analysis was only conducted on the total number of animals remaining at the last scan (i.e., MRI1-3, n = 22).
Thiamine deficiency model
This study initially included 22 male rats weighing 319.5 ± 12.0 g at baseline (i.e., MR1) and lasted a total of 21 days. Three days after acclimation and baseline scanning (MR1) on day 0, all 22 rats were put on thiamine-deficient chow (Harlan TD81029) and then triaged into three groups. The first group (thiamine-treated, EtOH-treated, TE) included five rats given thiamine replacement for 11 days (0.4 g/kg of 0.2 mg/ml thiamine, by intraperitoneal (IP) injection, once per day (Q.D.)) and exposed to 2 cycles of 4 days of EtOH (i.g.) treatment starting on days 3 and 10 (with 2 days of no EtOH exposure in between the two EtOH exposure cycles). The second group (pyrithiamine-treated, EtOH-treated, PE) included nine rats that were given pyrithiamine, an inhibitor of thiamine metabolism, for 11 days (0.5 g/kg of 0.15 mg/ml pyrithiamine, IP, Q.D.) and exposed to 2 cycles of 4 days of EtOH (i.g.) treatment starting on days 3 and 10 (with 2 days of no EtOH exposure in between). The third group (pyrithiamine-treated, saline-treated, PS) included eight rats that were also given pyrithiamine for 11 days (0.5 g/kg of 0.15 mg/ml pyrithiamine, IP, Q.D.), but during exposure periods, these animals received saline instead of EtOH.
During each EtOH exposure, EtOH-treated rats received an initial loading dose of 5 g/kg of 20 % EtOH w/v via oral gavage then a maximum of 3 g/kg every 8 h for 4 days. On each of the 4 days of EtOH treatment, animals were weighed; tail vein blood samples were collected four times per day: ∼90 min before each dose to determine the level of intoxication before further dosing or 90 min after the second dose of the day (i.e., 1500 hours) to determine peak BALs. The plasma was assayed for alcohol content based on direct reaction with the enzyme alcohol oxidase (Analox Instruments Ltd., UK). EtOH was administered according to body weight, BALs, and behavioral intoxication state assessed using a modified Majchrowicz scale (range 0-5: 0 = normal, 1 = sedation, 2 = mild ataxia, 3 = moderate ataxia, 4 = severe ataxia, and 5 = loss of righting reflex) (Majchrowicz 1975) . Average BALs (average of BALs measured at 0730 hours on each of the 4 days) achieved during each EtOH exposure period were as follows: 1: TE = 281.8 ± 5.7 mg%, PE = 279.6 ± 4.5 mg%, PS = 15.0 ± 0.4 mg%; 2: TE = 237.1 ± 5.1 mg%, PE = 247.4 ± 8.5 mg%, PS = 16.4 ± 0.7 mg%.
Animals underwent follow-up scans immediately after each of the two EtOH exposure periods (MR2 on day 7 and MR3 on day 14). During the recovery period, which began immediately after the second EtOH exposure scan (i.e., MR3), all animals were put on thiamine-replete chow (Harlan 7001) and given thiamine replacement (0.4 g/kg of 0.4 mg/ml, IP, Q.D.) for 7 days until the recovery scan (MR4 on day 21, Fig. 1(c) ). One PE animal died the day after MR2 for unknown reasons. MRS data from one PS animal were missing for MR3. The remaining animals (n = 21) were euthanized the day after recovery scans (i.e., day 22). MRS data analysis included as many animals as possible (i.e., MRS1, n = 22; MRS2, n = 22; MRS3, n = 20; MRS4, n = 21); MRI analysis was only conducted on the total number of animals remaining at the last scan (i.e., MRI1-4, n = 21).
Additional methods
For additional methods, including behavioral assay, details regarding MRI and MRS scanning and analysis, liver and chemistry blood panel assays, and liver and intestinal postmortem histopathology, please refer to Supplementary Materials.
Statistical analysis
Repeated measures analysis of variance (ANOVA) was used to evaluate group-to-time interactions for weight, ventricular volume, and metabolite levels in each experiment. Only interactions involving group effects were of interest to this analysis. Follow-up included three-group ANOVAs for the thiamine deficiency experiment. Otherwise, follow-up comparisons were conducted using Wilcoxon rank sum nonparametric tests. Correlations were evaluated between variables showing group effects, included all animals in each study, and used nonparametric Spearman's ρ. 
Results
Effects of treatment on weight and behavior
Liver damage model
A two-group (control (Ctrl) vs. CCl 4 )-by-four-time point repeated measures ANOVA for weight showed a group-to-time interaction (F(3, 30) = 20.98, p < .0001, Fig. 1(a) ). Follow-up indicated that CCl 4 animals weighed less than Ctrl animals on day 2 of treatment (p = .004) and at MR2 (p = .013). Animals treated with CCl 4 were hypoactive and lethargic showing piloerection and lacrimation. Food deprivation model A two-group (Ctrl vs. FD)-by-seven-time point repeated measures ANOVA for weight showed a group-to-time interaction (F(6, 120) = 71.15, p < .0001, Fig. 1(b) ), with FD animals beginning to weigh less than Ctrl animals starting on day 1 of food deprivation (p = .003) through MR2 (p < .0001). Weights between the two groups, however, were indistinguishable at the recovery scan (p = .55). Following 4 days of food deprivation, FD rats relative to Ctrl animals were hypoactive and lethargic but showed no other physiological or behavioral impairments.
Thiamine deficiency model
A repeated measures ANOVA evaluating weight among the three groups (TE, PS, and PE) at four time points (baseline MRI1, MRI2, MRI3, and recovery MRI4) showed a group-totime interaction (F(6, 54) = 7.58, p < .0001, Fig. 1(c) ). Followup three-group ANOVAs showed group effects at MR2 (F(2, 21) = 35.68, p < .0001; TE = PE < PS, p < .0001), MR3 (F(2, 20) = 14.36, p = .0002; PE < TE = PS, p ≤ .0004), and MR4 (F(2, 20) = 3.99, p = .0368; PE < TE = PS, p ≤ .03). Previous studies (e.g., Zahr et al. 2014a , b, c) to achieve thiamine deficiency report that approximately 12 days of pyrithiamine treatment is required to observe ataxia of gait (Langlais and Savage 1995) , after which seizures can occur (Zhang et al. 1995) . To avoid such potential complications in the context of combined thiamine deficiency and two bouts of EtOH exposure, thiamine-deficient animals (i.e., PS and PE animals) were exposed only to 11 days of thiamine deficiency.
Physiological changes in all three groups of animals included elevated heart rate, elevated respiration rate, and piloerection. TE animals showed no other behavioral effects. At most two of eight PS animals showed behavioral changes including reduced trunk tone, gait disturbances, and tremor. PE animals most frequently showed behavioral changes with, for example, as many as seven of nine animals were observed in a hunched position on day 11 (see supplementary Fig. S1 ).
Effects of treatment on ventricular/CSF volume
Liver damage model
Exemplary MR images from treated (CCL 4 ) and untreated (Ctrl) animals indicating lateral ventricles and cisterns are presented in Fig. 2 . Two-group (Ctrl vs. CCl 4 )-by-two-time point (MRI1 and MRI2) repeated measures ANOVAs did not demonstrate group or interaction effects for volume measures (i.e., lateral ventricles, cisterns, total CSF, Fig. 3a ).
Food deprivation model
Separate two-group (Ctrl vs. FD)-by-three-time point (MRI1, MRI2, and MRI3) repeated measures ANOVAs for each volume showed only a modest (not statistically significant) interaction effect of food deprivation on cisterns (F(2, 40) = 3.20, p = .05): cisterns were larger in the FD relative to the Ctrl group following food deprivation (p = .09), but this nominal difference was no longer evident after 1 week of recovery (p = .64, Fig. 3b ).
Thiamine deficiency model
For the thiamine deficiency + EtOH study, a three-group (TE, PS, and PE)-by-four-time point (MRI1, MRI2, MRI3, and MRI4) repeated measures ANOVA showed significant group-to-time interactions for lateral ventricles (F(6, 54) = 2.39, p = .04) and total CSF (F(6, 54) = 2.92, p = .02) (Fig. 3c) . For lateral ventricles, volumes were different between groups at MRI2 (F(2, 18) = 4.88, p = .02; PE > PS, p = .007), MRI3 (F(2, 18) = 6.38, p = .008; PE > PS, p = .02; PE > TE, p = .004), and MRI4 (F(2, 18) = 7.09, p = .005; PE > PS, p = .006; PE > TE, p = .004). Total CSF volume was different between groups at MRI2 (F(2, 18) = 6.41, p = .008; PE > PS, p = .002) and MRI3 (F(2, 18) = 5.94, p = .01; PE > PS, p = .01; PE > TE, p = .006).
Effects of treatment on brain metabolites
Liver damage model
The only metabolite that showed an interaction effect following liver damage was Cho (F(1, 10) = 6.92, p = .03) (Fig. 4a) . Follow-up tests demonstrated that Cho levels were lower (by ∼20 %) in liver damage relative to Ctrl animals at MRS2 (p = .01).
Food deprivation model
The only metabolite that showed an interaction effect following food deprivation was Cho (F(2, 40) = 6.07, p = .005) (Fig. 4b) . Follow-up tests demonstrated that Cho levels were nominally, but not statistically, lower (by ∼8 %) in fooddeprived relative to Ctrl animals at MRS2 (p = .06). At MRS3, following a week of recovery, Cho levels were no longer distinguished in the two groups (p = .2).
Thiamine deficiency model
In the thiamine deficiency + EtOH study, NAA and Cho metabolite levels were affected by treatment (Fig. 4c) . A threegroup-by-four-time point repeated measures ANOVA for NAA showed a nominal (not statistically significant) interaction effect (F(6, 51) = 1.95, p = .09). NAA levels were different between pairs of groups at MRS3 (F(2, 17) = 2.96, p = .08; PE < TE, p = .05; PS < TE, p = .04). A three-group-byfour-time point repeated measures ANOVA for Cho showed an interaction (F(6, 51) = 4.46, p = .001). Cho levels were significantly different between groups at MRS3 (F(2, 17) = 8.34, p = .003; PE < TE, p = .0118; PS < TE, p = .0008).
Additional results
For additional results, including effects of treatment on hematological indices, liver and intestinal histopathology, and relationships between blood and brain markers, please refer to Supplementary Materials.
Discussion
The finding of note from these experiments is that in contrast to EtOH exposure models (e.g., Zahr et al. 2010 Zahr et al. , 2009b ) and findings in non-abstinent chronic heavy drinkers ) and social and moderate drinkers (Ende et al. 2006) , which are associated elevations in Cho levels, liver damage caused by CCl 4 and thiamine deficiency accelerated by pyrithiamine each caused a reduction in the levels of Cho. Indeed, while unexpected, food deprivation and the accompanying weight loss were also associated with reductions, although nominal, in Cho levels.
The observed decrease in Cho in the CCl 4 model replicates findings in humans with cirrhosis (Cordoba et al. 2001; Geissler et al. 1997; Kreis et al. 1992; Laubenberger et al. 1997; Lee et al. 1999; Ross et al. 1994 ) and animal models of liver failure that also report reduced levels of Cho (e.g., Chavarria et al. 2013; de Graaf et al. 1991; Peeling et al. 1993; Rackayova et al. 2015) . Similarly, as has previously been reported in the literature of MRS case studies of WE (Mascalchi et al. 2002; Murata et al. 2001 ) and models of thiamine deficiency in rats treated with pyrithiamine hydrochloride (Lee et al. 2001 (Lee et al. , 1995 Pfefferbaum et al. 2007; Rose et al. 1993; Zahr et al. 2014a) , lower levels of both NAA and Cho were observed in pyrithiamine-treated relative to control rats. In the combined thiamine deficiency + EtOH exposure group, however, levels of Cho were not as low as in the thiamine deficiency group only.
A reduced Cho peak is observed in patients with disturbed energy metabolism (Bluml et al. 1998 ) and may be relevant to the primary biochemical lesion in thiamine deficiency (Lee et al. 2001; Murata et al. 1999) . On the other hand, reduced Cho may reflect disrupted osmoregulation (Hazell 2009; Hazell and Butterworth 2009) as glycerophosphocholine, one of the compounds included in the Cho signal, plays an important role in peripheral osmotic regulation (Gallazzini and Burg 2009) . Changes in osmoregulation may also disrupt white matter integrity, as reported in thiamine deficiency (He et al. 2007; Langlais and Savage 1995; Langlais and Zhang 1997) and liver failure (Rovira et al. 2008 (Rovira et al. , 2002 .
The Cho findings corroborate and extend those reported in human studies and speak to the lability of the signal arising from choline-containing compounds (i.e., Cho) (Zahr et al. 2015a (Zahr et al. , 2014c . For example, in a sample of 71 human subjects with either human immunodeficiency virus (HIV) infection (n = 33) or a comorbidity of HIV + alcohol use disorder (AUD, n = 38), Cho levels were higher in those who had experienced an acquired immune deficiency syndrome (AIDS)-defining event or who had hepatitis C but lower in individuals with low thiamine levels and those on highly active antiretroviral treatment (HAART) of HIV (Zahr et al. 2014c) . In a sample of 20 human subjects with AUD, Cho levels were higher in individuals who drank in binge-like patterns and those with a longer length of dependence but lower in those who have more recent drinking and those AUD individuals with past stimulant use (Zahr et al. 2015a) . The fact that the MRS-detectable Cho signal is composed of phosphocholine, glycerophosphocholine, and free choline, among other choline derivatives (Boulanger et al. 2000) , may explain, in part, the variability in the observed signal. In severe weight loss, for example, levels of phosphocholine can decrease while levels of glycerophosphocholine can increase (Gopel et al. 2002) .
No changes in CSF volumes were observed in the liver damage model. In the thiamine deficiency model, changes in ventricular volume were compounded, with PE animals showing both lateral ventricle enlargement and total CSF volume increase following just 4 days of pyrithiamine treatment + a single 4-day EtOH exposure. Further treatment (7 days of pyrithiamine + another EtOH exposure) caused a greater increase in volumes of the lateral ventricles and CSF in the PE group. These findings in the PE group are consistent with enlargement of the lateral ventricles observed with MRI in thiamine-deficient rats (i.e., equivalent to the PS group in this study) (Dror et al. 2010 (Dror et al. , 2014 Zahr et al. 2014a ). In the previous studies, however, ventricular enlargement was more profound and appeared to persist (Dror et al. 2010 (Dror et al. , 2014 , possibly because the length of thiamine deficiency was longer (14 days) and thiamine replacement was shorter (3 days) (Dror et al. 2010 (Dror et al. , 2014 . Although the TE group did not show statistically significant group effects, lateral ventricle and total CSF volumes increased following the first EtOH exposure period. Unlike our repeated EtOH exposure experiment (Zahr et al. 2015b ), however, there was a relatively suppressed effect of the second EtOH exposure on the lateral ventricular volume in the TE group. One potential explanation for the attenuated effect of the second EtOH treatment is that these EtOHexposed animals were being given daily injections of thiamine. This raises the intriguing possibility that thiamine given concurrently with EtOH treatment may counteract EtOH effects on ventricular volume enlargement (Zahr et al. 2013 ).
An unexpected finding was the modest increase in cistern volume following food deprivation. The pattern of hematological changes observed in the food deprivation experiment is consistent with malnutrition (e.g., low ALT, low alkaline phosphatase, low calcium, low carbon dioxide, low glucose, low cholesterol, low phosphorus) or dehydration (e.g., high albumin, high sodium, high chloride, low carbon dioxide, low creatinine). Reversible ventricular enlargement has been observed in anorexia nervosa (Enzmann and Lane 1977; Gerner et al. 1984) . As the effects on ventricular volume were reversible in all the experiments presented herein, this metric does not likely index atrophy of surrounding regions but may be related to changes in osmotic balance in the brain (c.f., Zahr et al. 2013) .
The postmortem liver histopathology assays clearly distinguish effects of CCl 4 and pyrithiamine. In contrast to the necrosis and fibrosis observed in livers from the CCl 4 -treated animals, the liver pathology in pyrithiamine-treated animals was mild and included minimal inflammation. The toxic metabolite of CCl 4 is produced by cytochrome P450 enzymes, which are highly concentrated in centrilobular hepatocytes. Combined with the fact that they get the least amount of oxygenated blood in the liver, relying on glycolysis for energy, CCl 4 toxicity first manifests and is overall most severe in centrilobular hepatocytes (Kumar et al. 2005; Vulimiri et al. 2011) .
In summary, this study distinguishes the effects of alcohol intoxication on the brain from the effects of common concomitants of alcoholism including liver damage and thiamine deficiency. Whereas alcohol exposure models of animals (both acute and chronic) are associated with elevated Cho levels, CCl 4 and pyrithiamine treatment results in reduced Cho levels. Liver damage does not appear to independently affect CSF volume, although EtOH and pyrithiamine treatment each causes nonspecific ventricular enlargement. Together, these results suggest that the pattern of changes often observed in individuals with AUD, including low levels of Cho relative to healthy controls (Bendszus et al. 2001; Durazzo et al. 2004; Ende et al. 2005; Fein et al. 1994; Parks et al. 2002; Seitz et al. 1999) , may be related to common non-alcohol concomitants of chronic alcoholism.
